Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Form 8.5 (EPT/NON-RI)

13 Sep 2010 13:45

RNS Number : 5814S
Nomura Code Securities Limited
13 September 2010
 



FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nomura Code Securities Ltd

(b) Name of offeree in relation to whose relevant securities this form relates:

Silence Therapeutics Ltd

(c) Name of the party to the offer with which exempt principal trader is connected:

Silence Therapeutics Ltd

(d) Date dealing undertaken:

10 Sep 2010

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

 

NO

 

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.0

563,377

0.2

(2) Derivatives (other than options):

0

(3) Options and agreements to purchase/sell:

0

 

TOTAL:

0

0.0

563,377

0.2

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ord shares

Purchase

35,000

11.5 p

Total

Purchases:

35,000

Ord shares

Sale

428,449

11.67 p

Total

Sales:

428,449

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

13 Sep 2010

Contact name:

Niall Campbell

Telephone number:

020 7776 1226

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEOUOSURRSAKAAR
Date   Source Headline
4th Jun 20148:32 amRNSNotice of AGM
7th May 20145:05 pmRNSHolding(s) in Company
7th May 201412:03 pmRNSHolding(s) in Company
29th Apr 20144:30 pmRNSResult of Placing
28th Apr 20145:21 pmRNSProposed Placing to raise a minimum of £10 million
28th Apr 20147:00 amRNSGene knockdown in non-human primates
19th Mar 20147:02 amRNSPotential Equity Fundraising
19th Mar 20147:00 amRNSPreliminary Results - Year Ended 31 December 2013
27th Feb 20147:00 amRNSYear end trading update
26th Feb 201412:09 pmRNSHolding(s) in Company
24th Feb 20143:41 pmRNSHolding(s) in Company
23rd Jan 201411:35 amRNSHolding(s) in Company
4th Dec 201311:39 amRNSHolding(s) in Company
22nd Nov 20134:00 pmRNSHolding(s) in Company
21st Nov 20136:25 pmRNSHolding(s) in Company
20th Nov 20135:00 pmRNSGrant of Options and Additional Listing
18th Nov 20137:02 amRNSInvestor Event and Appointment of NOMAD
18th Nov 20137:01 amRNSDirectorate and senior management changes
18th Nov 20137:00 amRNSNew Clinical Trial
8th Nov 20135:33 pmRNSHolding(s) in Company
5th Nov 20137:00 amRNSHolding(s) in Company
23rd Oct 20137:00 amRNSInvestor Day
17th Oct 20135:50 pmRNSHolding(s) in Company
17th Oct 20135:50 pmRNSHolding(s) in Company
17th Oct 20135:50 pmRNSHolding(s) in Company
23rd Sep 20138:33 amRNSHalf Yearly Report
19th Sep 20137:00 amRNSDate of Interim Announcement
30th Aug 20132:46 pmRNSHolding(s) in Company
21st Aug 20137:00 amRNSDirectorate Change
16th Aug 201312:29 pmRNSHolding(s) in Company
8th Aug 20137:00 amRNSAtu027 Phase I/II Update
12th Jul 20134:32 pmRNSHolding(s) in Company
3rd Jul 20137:00 amRNSCancellation of warrants
26th Jun 20132:47 pmRNSResult of AGM
26th Jun 20139:00 amRNSIssue of Options
26th Jun 20137:00 amRNSDirectorate Change
18th Jun 20137:00 amRNSAtu027 update: progression into Phase IIa
7th Jun 20134:35 pmRNSPrice Monitoring Extension
3rd Jun 20134:35 pmRNSPrice Monitoring Extension
3rd Jun 201311:30 amRNSNotice of AGM
29th May 20137:01 amRNSFinal Results
29th May 20137:00 amRNSDirectorate Change
2nd May 20134:52 pmRNSHolding(s) in Company
2nd May 20133:55 pmRNSHolding(s) in Company
2nd May 20133:52 pmRNSHolding(s) in Company
2nd May 20133:26 pmRNSHolding(s) in Company
29th Apr 201312:15 pmRNSResult of EGM
10th Apr 20137:00 amRNSPlacing and Share Consolidation
8th Mar 20137:00 amRNSExercise of warrants
5th Mar 20139:00 amRNSBusiness Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.